Researchers at MIT have developed a new nutrient fortification process “to deliver essential nutrients such as iron and iodine in foods and drinks,” reports Ben Cornwell for New Food Magazine. “With around two billion people worldwide suffering from iron deficiency, which can lead to anemia, impaired brain development in children and higher infant mortality, this solution from MIT could address a major global issue,” writes Cornwell.
Researchers at MIT used AI to “design antibiotics that can tackle hard-to-treat infections gonorrhoea and MRSA,” reports ITV News. "Our work shows the power of AI from a drug design standpoint, and enables us to exploit much larger chemical spaces that were previously inaccessible,” says Prof. James Collins.
Using AI, researchers at MIT have developed new antibiotics for gonorrhoea and MRSA, two infections that are typically hard to treat. The team “trained the AI to help it learn how bacteria was affected by different molecular structures built of atoms in order to design new antibiotics,” writes Ruth Stainer for the Daily Mail. “[A]nything too similar to the current antibiotics available, or with the potential to be toxic to human beings, was eradicated.”
With the help of a newly designed machine learning algorithm, researchers at MIT and elsewhere have spotted a “never-before-seen type of supernova that involves a nearby black hole,” reports Andrew Paul for Popular Science. “We’re now entering an era where we can automatically catch these rare events as they happen, not just after the fact,” said postdoctoral scholar Alex Gagliano. “That means we can finally start connecting the dots between how a star lives and how it dies, and that’s incredibly exciting.”
After observing the collision between a supernova and a black hole, researchers at MIT and elsewhere are rethinking our understanding of the life and death of stars, reports Jeanine Santucci for USA Today. "One of the only reasons that we were able to make this discovery and understand how scientifically interesting it was was through the combination of researchers in machine learning and in astrophysics," says postdoctoral scholar Alex Gagliano.
Prof. Daniela Rus, director of CSAIL, speaks with CBS News reporter Tony Dokoupil about her work developing AI-powered robots. “AI and robots are tools,” says Rus. “They are tools created by the people, for the people. And like any other tools they’re not inherently good or bad; they are what we choose to do with them. And I believe we can choose to do extraordinary things.”
Using generative AI, researchers at MT have designed new antibiotics to combat MRSA and gonorrhea, reports James Gallagher for the BBC. "We're excited because we show that generative AI can be used to design completely new antibiotics," says Prof. James Collins. "AI can enable us to come up with molecules, cheaply and quickly and in this way, expand our arsenal, and really give us a leg up in the battle of our wits against the genes of superbugs."
Prof. Philip Isola speaks with Fast Company reporter Victor Dey about the impact and use of agentic AI. “In some domains we truly have automatic verification that we can trust, like theorem proving in formal systems. In other domains, human judgment is still crucial,” says Isola. “If we use an AI as the critic for self-improvement, and if the AI is wrong, the system could go off the rails.”
Using an AI algorithm, researchers at MIT and elsewhere have been able to identify a previously unobserved explosion in the universe that they consider a “new flavor of supernova,” reports Kasha Patel for The Washington Post. “We think that statistically we’re overdue for a supernova in our own galaxy,” says postdoctoral scholar Alex Gagliano. “There are many people that are trying to establish early warning systems so that as soon as our telescopes pick up on something unusual, we can all aim our telescopes in that location.”
Prof. Daron Acemoglu speaks with WBUR’s Here & Now co-host Scott Tong about the role of institutions in the overall prosperity of nations and some of the current challenges facing the US. “It’s a very important part of rebuilding democracy that we have to make experts trusted again. And that has to start with us,” says Acemoglu. “We have to be much more down to Earth. We have to be honest about when we are certain of something and when we are uncertain. And, I think we have to make certain that it’s not our political views that drive our advice or our analysis.”
Principal Research Scientist Andrew McAfee speaks with New York Times reporter Steve Lohr about why companies are not yet seeing the economic payoff of AI implementation in the workforce. “It’s not surprising that early A.I. efforts are falling short,” said McAfee. “Innovation is a process of failing fairly regularly.”
Researchers at MIT have proposed that liquids, such as ionic fluids, are “what’s important for extraterrestrial habitability, and not just water,” reports Gayoung Lee for Gizmodo. If confirmed, this research would “dramatically expand what’s considered the ‘habitable zone’ among known exoplanets,” writes Lee. “By current standards, the habitable zone is defined as the band within planetary systems in which liquid water can remain stable on the surface. When it comes to life, we’re understandably biased towards water; all life as we know it depends on it.”
Writing for Fast Company, Rizwan Virk '92 explains the findings of his new book, “The Simulation Hypothesis.” The book explores the mysteries of quantum weirdness, “the strange nature of time and space, information theory & digital physics, spiritual/religious arguments, and even an information-based way to explain glitches in the matrix,” writes Virk.
Prof. Carlo Ratti speaks with The Boston Globe columnist Jason Schwartz about how a proposed seven-story office building behind Fenway Park could make the beloved Green Monster wall appear a bit less monstrous. “The wall has always felt monumental not just because of its size, but because it stood against an open sky,” says Ratti. “When the backdrop becomes a building, the view compresses, and the Monster might lose some of its presence.”
Prof. Giovanni Traverso and his lab are developing “a transdermal patch that could provide women with long-term contraception,” reports The Boston Globe Editorial Board. “The lab is also developing probiotic medications to treat abnormalities in the vaginal microbiome, a condition associated with risks including painful infection and premature birth.”